Sign inJoin waitlistJoin the waitlist

Bj Rimel

Division Chief, Gynecologic… · University of Washington School of Medicine

Credentials: · · · · · ·

History

Gynecologic… Division · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Gynecologic Oncology
Washington University School of Medicine
2011–2014
Obstetrics and Gynecology
Prentice Women's Hospital
2007–2011
Duke University School of Medicine
1999–2003

Research

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
New England Journal of Medicine · 2016 · 2,004 citations
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
The Lancet Oncology · 2019 · 431 citations
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive…
Annals of Oncology · 2019 · 151 citations

Beth Karlan
18 papers
Andrew Li
17 papers
Christine Walsh
14 papers
Ilana Cass
14 papers
Bradley Monk
8 papers
Summer Dewdney
8 papers · 6 as a resident
David Mutch
6 papers
SM
Stewart Massad
6 papers
Ursula Matulonis
6 papers
Kenneth Kim
5 papers
JH
Jean Hurteau
4 papers
Kathleen Moore
4 papers

Clinical trials

Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer
Principal investigator · Completed · Early phase 1
Marc Goodman
2021–2025
A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
Principal investigator · Completed · Phase 2
Cedars-Sinai Medical Center
2016–2022
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Site PI · Recruiting · Phase 2
GlaxoSmithKline
2021–2026
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Site PI · Unknown · Phase 3
Gynecologic Oncology Group
2012